Agenda van de ACRON
De ACRON is de branchevereniging van CRO’s in Nederland. Wij behartigen de collectieve belangen van de aangesloten bedrijven (leden). Dit doen we door middel van het organiseren van bijeenkomsten, zowel besloten als open, netwerk en lobby activiteiten met als voornaamste doel om Nederland als onderzoeksland optimaal te laten functioneren. Bekijk hieronder de agenda van evenementen van de ACRON en Contract Research Organisaties (CRO’s) in Nederland:
-
di29sep202015:00 - 16:30 uurOnline event
A webinar to consider the impact of the pandemic on data collection and data management – guidelines and practical advice
- How the pandemic has affected data collection in clinical trials and other studies.
- Current EMA and FDA guidance on data collection in studies affected by COVID-19.
- What does all this mean for my study?
- Considerations for patient collected data.
- Practical considerations for implementing the guidance to overcome the current challenges.
- Data collection perspectives for future studies.
- The emerging trend of virtual studies, digital technologies, and telemedicine to mitigate future risks to data collection in clinical research
Rate: £75 + VAT
-
wo04nov202009:00 - 18:00De Reehorst, Ede
Deze bijeenkomst is definitief afgelast
-
di17nov202013:30 - 17:30Online event
Register now for the RSNN virtual workshopRegistration for the virtual RSNN workshop organized together with EMA on 17 November 2020: "Leveraging the value of collaboration - from regulatory science to regulatory innovation" is now open.Online event broadcasted from Villa Jongerius in Utrecht (Zoom meeting)Date: Tuesday 17 November 2020, 13:30 - 17:30
Registration: Free of charge
Target audience: Experts from EMA, academia, (bio)pharmaceutical industry, patient communities, regulatory authorities and the medical professionThis year’s workshop will be chaired by Sabine Straus (CBG-MEB). In this RSNN workshop we explore the key regulatory science questions in the coming years, and especially address how collaborative research can be of most value for regulators, patients, companies, HTA bodies, academia and other stakeholders. Discussions with the audience, representing various backgrounds are a critical element in this respect.In the first part of the workshop, experts will share their point of view on the main theme, including among others Tony Humpreys (European Medicines Agency), Marjon Pasmooij (CBG-MEB) and Jarno Hoekman (Utrecht University). In the second part, 10-minute presentations will be given by a number of speakers on recent regulatory science case studies, with special attention to key success factors. The workshop will close with a discussion session and final remarks from Tony Humpreys. On behalf of the program committee,RSNN secretariat in collaboration with our media partner Vital Transformation.